Formulation: A 1 mg/ml solution in methanol

• BAY-1470

Formulation: A 100 μg/ml solution in methanol

• 4-carbomethoxy Fentanyl
• Carfentanyl

Formulation: A 1 mg/ml solution in methanol

Formulation: A 1 mg/ml solution in methanol

• p-hydroxy Xylazine
• para-hydroxy Xylazine

Formulation: A solid

Purity: ≥99% (deuterated forms d₁-d₆)

Formulation: A crystalline solid

Purity: ≥98%

• BAY-1470

Formulation: A crystalline solid

Purity: ≥98%

• NSC 40030

Formulation: A 1 mg/ml solution in methanol

• D-Methorphan-d₃
• DXM-d₃

Formulation: A crystalline solid

Purity: ≥98%

• p-Acetophenetidide
• 4′-Ethoxyacetanilide
• NSC 7651

Formulation: A neat solid

Purity: ≥98%

• Methyltheobromine
• NSC 5036

Formulation: A 1 mg/ml solution in methanol

• NSC 9848
• NSC 128143
• Phenobarbitone

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A neat solid

Purity: ≥98%

• NSC 177023
• R 12654
• L-Tetramisole

Formulation: A neat solid

Purity: ≥98%

• Methyltheobromine-d₃

Formulation: A neat solid

Purity: ≥98%

• 4-Acetamidophenol-d₄
• APAP-d₄
• 4'-Hydroxyacetanilide-d₄

Formulation: A 1 mg/ml solution in methanol

• Methyltheobromine-¹³C₃

Formulation: A neat solid

Purity: ≥98%

Schedule: IV

• NSC 9848
• NSC 128143
• Phenobarbitone

Formulation: A 1 mg/ml solution in methanol

• NSC 177023
• R 12654
• L-Tetramisole

Formulation: A crystalline solid

Purity: ≥99% deuterated forms (d₁-d₆)

• p-hydroxy Xylazine-d₆
• para-hydroxy Xylazine-d₆

Formulation: A 1 mg/ml solution in acetonitrile

• Bis(2,2,6,6-tetramethyl-4-piperidyl) sebacate
• GW 480
• HALS770
• T770
• Tinuvin 770

Formulation: A neat solid

Purity: ≥98%

• 4-Acetamidophenol
• APAP
• 4'-Hydroxyacetanilide
• NSC 3991
• NSC 109028
• Paracetamol

Formulation: A crystalline solid

Purity: ≥98%

• DXM
• D-Methorphan

Formulation: A crystalline solid

Purity: ≥98%

• 1,3-Dimethylxanthine
• NSC 2066

Formulation: A 1 mg/ml solution in methanol

• Methyltheobromine
• NSC 5036

Formulation: A crystalline solid

Purity: ≥98%

• Novocaine